Japan · Delayed Price · Currency is JPY Healios K.K. Statistics
Total Valuation
Healios K.K. has a market cap or net worth of JPY 39.02 billion. The enterprise value is 32.54 billion.
| Market Cap | 39.02B |
| Enterprise Value | 32.54B |
Important Dates
The next confirmed earnings date is Thursday, November 12, 2026.
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Healios K.K. has 135.00 million shares outstanding. The number of shares has increased by 40.44% in one year.
| Current Share Class | 135.00M |
| Shares Outstanding | 135.00M |
| Shares Change (YoY) | +40.44% |
| Shares Change (QoQ) | +15.77% |
| Owned by Insiders (%) | 21.47% |
| Owned by Institutions (%) | 8.18% |
| Float | 69.86M |
Valuation Ratios
The trailing PE ratio is 188.48.
| PE Ratio | 188.48 |
| Forward PE | n/a |
| PS Ratio | 661.28 |
| PB Ratio | 4.43 |
| P/TBV Ratio | 8.95 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 157.19 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.37, with a Debt / Equity ratio of 0.29.
| Current Ratio | 2.37 |
| Quick Ratio | 2.22 |
| Debt / Equity | 0.29 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.59 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 4.25% and return on invested capital (ROIC) is -374.08%.
| Return on Equity (ROE) | 4.25% |
| Return on Assets (ROA) | -13.02% |
| Return on Invested Capital (ROIC) | -374.08% |
| Return on Capital Employed (ROCE) | -22.05% |
| Weighted Average Cost of Capital (WACC) | 11.28% |
| Revenue Per Employee | 786,667 |
| Profits Per Employee | 2.76M |
| Employee Count | 75 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Healios K.K. has paid 85.00 million in taxes.
| Income Tax | 85.00M |
| Effective Tax Rate | 28.43% |
Stock Price Statistics
The stock price has decreased by -51.11% in the last 52 weeks. The beta is 1.41, so Healios K.K.'s price volatility has been higher than the market average.
| Beta (5Y) | 1.41 |
| 52-Week Price Change | -51.11% |
| 50-Day Moving Average | 265.24 |
| 200-Day Moving Average | 327.41 |
| Relative Strength Index (RSI) | 53.41 |
| Average Volume (20 Days) | 1,867,195 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Healios K.K. had revenue of JPY 59.00 million and earned 207.00 million in profits.
| Revenue | 59.00M |
| Gross Profit | -62.00M |
| Operating Income | -4.16B |
| Pretax Income | 299.00M |
| Net Income | 207.00M |
| EBITDA | -3.88B |
| EBIT | -4.16B |
| Earnings Per Share (EPS) | -7.51 |
Balance Sheet
The company has 9.07 billion in cash and 2.57 billion in debt, with a net cash position of 6.51 billion or 48.19 per share.
| Cash & Cash Equivalents | 9.07B |
| Total Debt | 2.57B |
| Net Cash | 6.51B |
| Net Cash Per Share | 48.19 |
| Equity (Book Value) | 8.80B |
| Book Value Per Share | 64.98 |
| Working Capital | 5.81B |
Cash Flow
In the last 12 months, operating cash flow was -4.10 billion and capital expenditures -283.00 million, giving a free cash flow of -4.39 billion.
| Operating Cash Flow | -4.10B |
| Capital Expenditures | -283.00M |
| Depreciation & Amortization | 279.00M |
| Net Borrowing | n/a |
| Free Cash Flow | -4.39B |
| FCF Per Share | -32.48 |
Margins
Gross margin is -105.08%, with operating and profit margins of -7,055.93% and 350.85%.
| Gross Margin | -105.08% |
| Operating Margin | -7,055.93% |
| Pretax Margin | 506.78% |
| Profit Margin | 350.85% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Healios K.K. does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -40.44% |
| Shareholder Yield | -40.44% |
| Earnings Yield | 0.53% |
| FCF Yield | -11.24% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Analyst Forecast
The average price target for Healios K.K. is 794.83, which is 176.94% higher than the current price. The consensus rating is "Buy".
| Price Target | 794.83 |
| Price Target Difference | 176.94% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | 300.38% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Healios K.K. has an Altman Z-Score of 1.9 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.9 |
| Piotroski F-Score | 3 |